Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/2/26 19:05 | 8/31/26 | GNLX | Health | Drug | Pharmaceutical Preparations | Cappello Joseph | CA | O | Chief Te | 5 | S.m | -48 | 3.00 | 0 | -16 | 329 | D | |||||||||||||||
9/2/26 19:05 | 8/31/26 | GNLX | Health | Drug | Pharmaceutical Preparations | Zindrick Thomas | CA | O | P,CEO | 5 | S.m | -184 | 3.02 | 0 | -61 | 1,261 | D | |||||||||||||||
9/2/26 19:05 | 8/31/26 | GNLX | Health | Drug | Pharmaceutical Preparations | Yu Yong | CA | O | Chief Sc | 5 | S.m | -49 | 3.03 | 0 | -16 | 268 | D | |||||||||||||||
7/2/26 16:35 | 7/1/26 | GNLX | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | D | 1 | S | -35 | 2.91 | 0 | -12 | 91 | D | ||||||||||||||||
6/4/26 20:35 | 6/3/26 | GNLX | Health | Drug | Pharmaceutical Preparations | Smalling Ralph | CA | O | Head of | 4 | S.m | -12 | 3.42 | 0 | -3 | 69 | D | |||||||||||||||
6/2/26 20:35 | 6/1/26 | GNLX | Health | Drug | Pharmaceutical Preparations | Thomas John | CA | D | 3 | S | -109 | 3.63 | 0 | -30 | 493 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |